Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to -$37000.0.

  • Ocugen's Gains from Investment Securities changed N/A to -$37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 2485.77%. This contributed to the annual value of $103000.0 for FY2024, which is 8199.3% down from last year.
  • As of Q3 2025, Ocugen's Gains from Investment Securities stood at -$37000.0.
  • Over the past 5 years, Ocugen's Gains from Investment Securities peaked at $951000.0 during Q4 2023, and registered a low of -$352000.0 during Q1 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was $5000.0 (2021), whereas its average is $188285.7.
  • In the last 5 years, Ocugen's Gains from Investment Securities crashed by 11967.21% in 2021 and then skyrocketed by 4765000.0% in 2023.
  • Over the past 5 years, Ocugen's Gains from Investment Securities (Quarter) stood at -$36000.0 in 2021, then soared by 94.44% to -$2000.0 in 2022, then soared by 47650.0% to $951000.0 in 2023, then crashed by 88.22% to $112000.0 in 2024, then crashed by 133.04% to -$37000.0 in 2025.
  • Its last three reported values are -$37000.0 in Q3 2025, $925000.0 for Q2 2025, and $428000.0 during Q1 2025.